Spots Global Cancer Trial Database for Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma

Official Title: Investigating Marrow Infiltrating Lymphocytes as a Source of Adoptive Cellular Therapy in Renal Cell Carcinoma and Urothelial Carcinoma

Study ID: NCT04341740

Conditions

Renal Cell Carcinoma

Urothelial Carcinoma

Interventions

Bone Marrow Aspirate

Study Description

Brief Summary: The purpose of this research is to collect health-related information as well as bone marrow and blood specimens to determine if a new form of treatment for patients with kidney and bladder cancer may be possible.

Detailed Description: This research will collect specimens from the bone marrow and blood to determine if a new treatment for kidney or bladder cancer may be possible. This research study will collect a bone marrow sample as well as a blood sample. Participation in the research study will last approximately 60 days which includes time to determine if the patient is eligible to participate in the study, perform the research procedures and follow-up with the patient following the research procedures to determine if they are experiencing any side effects. Participation will end approximately 30 days following the bone marrow collection. The bone marrow and blood samples will be collected from all patients in both cohorts only at a single time point, after they have been enrolled on the study.